Repros Therapeutics Inc. (RPRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

2408 TIMBERLOCH PL WOODLANDS, TX 77380

Repros Therapeutics Inc. a development stage biopharmaceutical company focuses on the development of drugs to treat hormonal and reproductive system disorders.

Are you looking for this stock instead?

View SEC Filings from RPRX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RPRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RPRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
46,015,330 2020-06-18 0

ENGELBERT CATHERINE M.

  • Director
0 2020-06-16 0

LLOYD GEORGE W. EVP, INVESTMENTS & GC

  • Officer
0 2020-06-15 0

BASSLER BONNIE L

  • Director
0 2020-06-15 0

NORDEN GREGORY

  • Director
35,715 2020-06-15 0

REDDOCH JAMES F. EVP, RESEARCH & INVESTMENTS

  • Officer
0 2020-06-15 0

RIGGS RORY B

  • Director
15,000 2020-06-15 0

DESOUZA ERROL B

  • Director
35,715 2020-06-15 0

COYNE TERRANCE P. EVP & CFO

  • Officer
0 2020-06-15 0

FORD WILLIAM E

  • Director
0 2020-06-15 0

HITE CHRISTOPHER EVP & VICE CHAIRMAN

  • Officer
70,000 2020-06-15 0

LEGORRETA PABLO G. CEO, CHAIRMAN OF THE BOARD

  • Officer
  • Director
0 2020-06-15 0

GIULIANI MARIO GERMANO

SKYELINE MANAGEMENT LTD

AVARA MANAGEMENT LTD

NOGRA GROUP SICAF SIF MGG STRATEGIC

NOGRA GROUP SICAF SIF GG STRATEGIC

NOGRA GROUP SICAF - SIF S.A.

SEVERGNINI ACHILLE G.

  • Director
  • 10% Owner
0 2020-06-15 0

GIULIANI MARIO GERMANO

SKYELINE MANAGEMENT LTD

AVARA MANAGEMENT LTD

NOGRA GROUP SICAF SIF MGG STRATEGIC

NOGRA GROUP SICAF SIF GG STRATEGIC

58,920,830 2020-06-15 0

CAIN DANIEL F

  • Director
No longer subject to file 2018-01-29 0

MASTERSON NOLA E

  • Director
No longer subject to file 2018-01-29 0

ANDERSON KATHERINE CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2018-01-29 0

WYLLIE MICHAEL

  • Director
No longer subject to file 2018-01-29 0

RAMASASTRY SAIRA

  • Director
No longer subject to file 2018-01-29 0

FOURTEAU PATRICK

  • Director
No longer subject to file 2018-01-29 0

DILLAHA LARRY INTERIM PRESIDENT AND CEO

  • Officer
0 2017-02-01 0

PODOLSKI JOSEPH PRESIDENT AND CEO

  • Officer
  • Director
107,422 2016-12-09 0

THOMPSON JAYE SEE REMARKS

  • Officer
0 2016-07-05 0

WERNICKE J. F. CHIEF MEDICAL OFFICER

  • Officer
0 2016-07-05 0

SUESSERMAN MICHAEL

  • Director
0 2015-05-28 0

WIEHLE RONALD VP, RESEARCH AND DEVELOPMENT

  • Officer
0 2014-03-26 0

PERCEPTIVE ADVISORS LLC

EDELMAN JOSEPH

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

  • 10% Owner
No longer subject to file 2013-03-15 0

FOURCROY JEAN L MD PHD MPH

  • Director
0 2012-06-13 0

OLIVEIRA STEVEN MICHAEL

  • 10% Owner
1,315,672 2011-04-19 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

  • 10% Owner
1,558,060 2011-03-16 0

EFFICACY CAPITAL, LTD.

EFFICACY BIOTECH FUND L.P.

LAPPE MARK

EFFICACY BIOTECH FUND LTD

EFFICACY BIOTECH MASTER FUND LTD.

  • 10% Owner
No longer subject to file 2009-12-17 0

REED JOHN C

  • Director
0 2009-05-20 0

LAPPE MARK

  • Director
  • 10% Owner
0 2009-05-20 0

HOWELL STEPHEN B.

  • Director
0 2009-05-20 0

VAN AS ANDRE MD, PHD CHIEF MEDICAL OFFICER

  • Officer
10,410 2009-04-14 0

PLOTH LOUIS JR VP & CHIEF FINANCIAL OFFICER

  • Officer
  • Director
0 2009-02-18 0

LAMMERS PAUL PRESIDENT

  • Officer
0 2009-02-18 0

HARDER JEFFREY R

  • Director
13,824 2008-11-18 0

EFFICACY CAPITAL, LTD.

EFFICACY BIOTECH FUND L.P.

EFFICACY BIOTECH FUND LTD

EFFICACY BIOTECH MASTER FUND LTD.

LAPPE MARK

KAYYEM JON FAIZ

  • 10% Owner
4,292,136 2008-10-31 0

POORVIN DAVID

  • Director
0 2008-05-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments